Artwork

Inhoud geleverd door PeerView, 24 West 40th Street, Suite 950, New York, NY 10018, PVI, and PeerView Institute for Medical Education. Alle podcastinhoud, inclusief afleveringen, afbeeldingen en podcastbeschrijvingen, wordt rechtstreeks geüpload en geleverd door PeerView, 24 West 40th Street, Suite 950, New York, NY 10018, PVI, and PeerView Institute for Medical Education of hun podcastplatformpartner. Als u denkt dat iemand uw auteursrechtelijk beschermde werk zonder uw toestemming gebruikt, kunt u het hier beschreven proces https://nl.player.fm/legal volgen.
Player FM - Podcast-app
Ga offline met de app Player FM !

Laura S. Dominici, MD, FACS - Navigating Complex Decisions at the Intersection of Local and Systemic Management of Early Breast Cancer

48:39
 
Delen
 

Manage episode 361757893 series 41876
Inhoud geleverd door PeerView, 24 West 40th Street, Suite 950, New York, NY 10018, PVI, and PeerView Institute for Medical Education. Alle podcastinhoud, inclusief afleveringen, afbeeldingen en podcastbeschrijvingen, wordt rechtstreeks geüpload en geleverd door PeerView, 24 West 40th Street, Suite 950, New York, NY 10018, PVI, and PeerView Institute for Medical Education of hun podcastplatformpartner. Als u denkt dat iemand uw auteursrechtelijk beschermde werk zonder uw toestemming gebruikt, kunt u het hier beschreven proces https://nl.player.fm/legal volgen.
Go online to PeerView.com/RGA860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Although the prognosis of patients with early breast cancer (EBC) has improved with earlier detection and more efficacious therapies, many patients still face poor outcomes, and there is an urgent need to prevent recurrences. An increasing number of systemic therapies have been recently approved in the perioperative settings of HR+, HER2+, and triple-negative breast cancer (TNBC), including immunotherapy, CDK4/6 inhibitor therapy, adjuvant PARP inhibitor therapy, and a number of HER2-targeted therapies. Other agents and combinations are undergoing evaluation in clinical trials and are likely to expand the systemic therapy arsenal for patients with EBC. With the increasing complexity of systemic and local treatment of patients with EBC, it is crucial for surgeons, medical oncologists, pathologists, and other members of the breast cancer care team to effectively collaborate and coordinate management strategies to ensure optimal treatment selection and planning with longer-term goals in mind. This PeerView educational activity, based on a recent live symposium, provides an overview of the essential evidence supporting the use of a growing number of perioperative systemic therapies for patients with different subtypes of EBC. Optimally integrating these therapies into practice with multidisciplinary collaboration is demonstrated through the use of case scenarios, highlighting the nuances of applying new data to clinical decision-making. Upon completion of this activity, participants should be better able to: Analyze the latest evidence and guidelines supporting the use of standard-of-care and novel/emerging therapies for different subtypes of early-stage breast cancer and their role as part of multimodal treatment plans; Apply best practices for multidisciplinary risk assessment and predictive/prognostic testing to inform treatment planning for patients with different subtypes of early-stage breast cancer; and Implement multidisciplinary and patient-centric strategies for shared decision-making to ensure the development and implementation of optimal, individualized treatment plans in different settings of early-stage breast cancer.
  continue reading

586 afleveringen

Artwork
iconDelen
 
Manage episode 361757893 series 41876
Inhoud geleverd door PeerView, 24 West 40th Street, Suite 950, New York, NY 10018, PVI, and PeerView Institute for Medical Education. Alle podcastinhoud, inclusief afleveringen, afbeeldingen en podcastbeschrijvingen, wordt rechtstreeks geüpload en geleverd door PeerView, 24 West 40th Street, Suite 950, New York, NY 10018, PVI, and PeerView Institute for Medical Education of hun podcastplatformpartner. Als u denkt dat iemand uw auteursrechtelijk beschermde werk zonder uw toestemming gebruikt, kunt u het hier beschreven proces https://nl.player.fm/legal volgen.
Go online to PeerView.com/RGA860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Although the prognosis of patients with early breast cancer (EBC) has improved with earlier detection and more efficacious therapies, many patients still face poor outcomes, and there is an urgent need to prevent recurrences. An increasing number of systemic therapies have been recently approved in the perioperative settings of HR+, HER2+, and triple-negative breast cancer (TNBC), including immunotherapy, CDK4/6 inhibitor therapy, adjuvant PARP inhibitor therapy, and a number of HER2-targeted therapies. Other agents and combinations are undergoing evaluation in clinical trials and are likely to expand the systemic therapy arsenal for patients with EBC. With the increasing complexity of systemic and local treatment of patients with EBC, it is crucial for surgeons, medical oncologists, pathologists, and other members of the breast cancer care team to effectively collaborate and coordinate management strategies to ensure optimal treatment selection and planning with longer-term goals in mind. This PeerView educational activity, based on a recent live symposium, provides an overview of the essential evidence supporting the use of a growing number of perioperative systemic therapies for patients with different subtypes of EBC. Optimally integrating these therapies into practice with multidisciplinary collaboration is demonstrated through the use of case scenarios, highlighting the nuances of applying new data to clinical decision-making. Upon completion of this activity, participants should be better able to: Analyze the latest evidence and guidelines supporting the use of standard-of-care and novel/emerging therapies for different subtypes of early-stage breast cancer and their role as part of multimodal treatment plans; Apply best practices for multidisciplinary risk assessment and predictive/prognostic testing to inform treatment planning for patients with different subtypes of early-stage breast cancer; and Implement multidisciplinary and patient-centric strategies for shared decision-making to ensure the development and implementation of optimal, individualized treatment plans in different settings of early-stage breast cancer.
  continue reading

586 afleveringen

Alle afleveringen

×
 
Loading …

Welkom op Player FM!

Player FM scant het web op podcasts van hoge kwaliteit waarvan u nu kunt genieten. Het is de beste podcast-app en werkt op Android, iPhone en internet. Aanmelden om abonnementen op verschillende apparaten te synchroniseren.

 

Korte handleiding